nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—SLCO1A2—Chlorambucil—ovarian cancer	0.387	0.54	CbGbCtD
Methyltestosterone—CYP19A1—Paclitaxel—ovarian cancer	0.17	0.237	CbGbCtD
Methyltestosterone—CYP19A1—follicular fluid—ovarian cancer	0.0443	0.29	CbGeAlD
Methyltestosterone—CYP3A4—Topotecan—ovarian cancer	0.0434	0.0606	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—ovarian cancer	0.0377	0.0526	CbGbCtD
Methyltestosterone—CYP3A4—Vinorelbine—ovarian cancer	0.0306	0.0427	CbGbCtD
Methyltestosterone—CYP19A1—corpus luteum—ovarian cancer	0.0256	0.167	CbGeAlD
Methyltestosterone—CYP3A4—Paclitaxel—ovarian cancer	0.0215	0.03	CbGbCtD
Methyltestosterone—CYP19A1—ovarian follicle—ovarian cancer	0.02	0.131	CbGeAlD
Methyltestosterone—CYP3A4—Docetaxel—ovarian cancer	0.0155	0.0217	CbGbCtD
Methyltestosterone—CYP3A4—Doxorubicin—ovarian cancer	0.0116	0.0162	CbGbCtD
Methyltestosterone—AR—oviduct—ovarian cancer	0.00777	0.0509	CbGeAlD
Methyltestosterone—Oligospermia—Epirubicin—ovarian cancer	0.00273	0.0536	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—ovarian cancer	0.00253	0.0496	CcSEcCtD
Methyltestosterone—AR—myometrium—ovarian cancer	0.00249	0.0163	CbGeAlD
Methyltestosterone—SHBG—endometrium—ovarian cancer	0.00244	0.016	CbGeAlD
Methyltestosterone—SHBG—gonad—ovarian cancer	0.00226	0.0148	CbGeAlD
Methyltestosterone—SHBG—uterus—ovarian cancer	0.00225	0.0147	CbGeAlD
Methyltestosterone—Amenorrhoea—Chlorambucil—ovarian cancer	0.00222	0.0437	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—ovarian cancer	0.00212	0.0417	CcSEcCtD
Methyltestosterone—SHBG—female reproductive system—ovarian cancer	0.00202	0.0132	CbGeAlD
Methyltestosterone—CYP19A1—endometrium—ovarian cancer	0.00198	0.013	CbGeAlD
Methyltestosterone—Azoospermia—Doxorubicin—ovarian cancer	0.00197	0.0386	CcSEcCtD
Methyltestosterone—AR—epithelium—ovarian cancer	0.00195	0.0128	CbGeAlD
Methyltestosterone—Venous thromboembolism—Epirubicin—ovarian cancer	0.00195	0.0382	CcSEcCtD
Methyltestosterone—Amenorrhoea—Melphalan—ovarian cancer	0.00194	0.0381	CcSEcCtD
Methyltestosterone—AR—uterine cervix—ovarian cancer	0.00194	0.0127	CbGeAlD
Methyltestosterone—SHBG—bone marrow—ovarian cancer	0.00191	0.0125	CbGeAlD
Methyltestosterone—AR—decidua—ovarian cancer	0.00184	0.0121	CbGeAlD
Methyltestosterone—SHBG—female gonad—ovarian cancer	0.00184	0.012	CbGeAlD
Methyltestosterone—CYP19A1—gonad—ovarian cancer	0.00183	0.012	CbGeAlD
Methyltestosterone—SHBG—vagina—ovarian cancer	0.00183	0.012	CbGeAlD
Methyltestosterone—CYP19A1—uterus—ovarian cancer	0.00182	0.0119	CbGeAlD
Methyltestosterone—Venous thromboembolism—Doxorubicin—ovarian cancer	0.0018	0.0354	CcSEcCtD
Methyltestosterone—AR—endometrium—ovarian cancer	0.00175	0.0115	CbGeAlD
Methyltestosterone—CYP19A1—female reproductive system—ovarian cancer	0.00164	0.0107	CbGeAlD
Methyltestosterone—SHBG—testis—ovarian cancer	0.00163	0.0107	CbGeAlD
Methyltestosterone—AR—gonad—ovarian cancer	0.00162	0.0106	CbGeAlD
Methyltestosterone—AR—uterus—ovarian cancer	0.00161	0.0106	CbGeAlD
Methyltestosterone—Menstruation irregular—Docetaxel—ovarian cancer	0.00153	0.0301	CcSEcCtD
Methyltestosterone—CYP19A1—female gonad—ovarian cancer	0.00149	0.00976	CbGeAlD
Methyltestosterone—AR—female reproductive system—ovarian cancer	0.00145	0.0095	CbGeAlD
Methyltestosterone—Dydrogesterone—PGR—ovarian cancer	0.00139	0.1	CrCbGaD
Methyltestosterone—SLCO1A2—testis—ovarian cancer	0.00135	0.00887	CbGeAlD
Methyltestosterone—ALB—testis—ovarian cancer	0.00135	0.00882	CbGeAlD
Methyltestosterone—CYP19A1—testis—ovarian cancer	0.00132	0.00866	CbGeAlD
Methyltestosterone—AR—female gonad—ovarian cancer	0.00132	0.00864	CbGeAlD
Methyltestosterone—AR—vagina—ovarian cancer	0.00131	0.00859	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Topotecan—ovarian cancer	0.0013	0.0256	CcSEcCtD
Methyltestosterone—CYP2B6—gonad—ovarian cancer	0.00118	0.00772	CbGeAlD
Methyltestosterone—AR—testis—ovarian cancer	0.00117	0.00767	CbGeAlD
Methyltestosterone—Nausea—Altretamine—ovarian cancer	0.00116	0.0229	CcSEcCtD
Methyltestosterone—Embolism venous—Epirubicin—ovarian cancer	0.00113	0.0223	CcSEcCtD
Methyltestosterone—Allylestrenol—PGR—ovarian cancer	0.00108	0.0781	CrCbGaD
Methyltestosterone—CYP2B6—female reproductive system—ovarian cancer	0.00105	0.00689	CbGeAlD
Methyltestosterone—Embolism venous—Doxorubicin—ovarian cancer	0.00105	0.0206	CcSEcCtD
Methyltestosterone—ALB—lymph node—ovarian cancer	0.000976	0.00639	CbGeAlD
Methyltestosterone—Amenorrhoea—Docetaxel—ovarian cancer	0.000965	0.019	CcSEcCtD
Methyltestosterone—CYP19A1—lymph node—ovarian cancer	0.000958	0.00628	CbGeAlD
Methyltestosterone—CYP2B6—vagina—ovarian cancer	0.000951	0.00623	CbGeAlD
Methyltestosterone—Haemoglobin—Topotecan—ovarian cancer	0.000878	0.0172	CcSEcCtD
Methyltestosterone—Haemorrhage—Topotecan—ovarian cancer	0.000873	0.0171	CcSEcCtD
Methyltestosterone—Alopecia—Chlorambucil—ovarian cancer	0.000867	0.017	CcSEcCtD
Methyltestosterone—Haemoglobin—Melphalan—ovarian cancer	0.000859	0.0169	CcSEcCtD
Methyltestosterone—Haemorrhage—Melphalan—ovarian cancer	0.000855	0.0168	CcSEcCtD
Methyltestosterone—CYP2B6—testis—ovarian cancer	0.000849	0.00556	CbGeAlD
Methyltestosterone—AR—lymph node—ovarian cancer	0.000848	0.00556	CbGeAlD
Methyltestosterone—Etonogestrel—PGR—ovarian cancer	0.000841	0.0608	CrCbGaD
Methyltestosterone—Megestrol acetate—PGR—ovarian cancer	0.000835	0.0604	CrCbGaD
Methyltestosterone—CYP3A4—female reproductive system—ovarian cancer	0.000794	0.0052	CbGeAlD
Methyltestosterone—Angiopathy—Topotecan—ovarian cancer	0.000792	0.0156	CcSEcCtD
Methyltestosterone—Alopecia—Topotecan—ovarian cancer	0.000772	0.0152	CcSEcCtD
Methyltestosterone—Alopecia—Melphalan—ovarian cancer	0.000756	0.0148	CcSEcCtD
Methyltestosterone—Drospirenone—PGR—ovarian cancer	0.000729	0.0527	CrCbGaD
Methyltestosterone—Allylestrenol—ESR1—ovarian cancer	0.000681	0.0493	CrCbGaD
Methyltestosterone—Angiopathy—Vinorelbine—ovarian cancer	0.000678	0.0133	CcSEcCtD
Methyltestosterone—Trilostane—ESR1—ovarian cancer	0.000664	0.048	CrCbGaD
Methyltestosterone—Mestranol—ESR1—ovarian cancer	0.000664	0.048	CrCbGaD
Methyltestosterone—Alopecia—Vinorelbine—ovarian cancer	0.00066	0.013	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Epirubicin—ovarian cancer	0.000651	0.0128	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—ovarian cancer	0.000651	0.0128	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Topotecan—ovarian cancer	0.00062	0.0122	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Melphalan—ovarian cancer	0.000607	0.0119	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000602	0.0118	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—ovarian cancer	0.000602	0.0118	CcSEcCtD
Methyltestosterone—Levonorgestrel—PGR—ovarian cancer	0.000595	0.043	CrCbGaD
Methyltestosterone—Paraesthesia—Topotecan—ovarian cancer	0.000557	0.0109	CcSEcCtD
Methyltestosterone—Paraesthesia—Melphalan—ovarian cancer	0.000545	0.0107	CcSEcCtD
Methyltestosterone—Danazol—PGR—ovarian cancer	0.000542	0.0392	CrCbGaD
Methyltestosterone—Etonogestrel—ESR1—ovarian cancer	0.000531	0.0384	CrCbGaD
Methyltestosterone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000531	0.0104	CcSEcCtD
Methyltestosterone—Spironolactone—PGR—ovarian cancer	0.000519	0.0375	CrCbGaD
Methyltestosterone—Haemoglobin—Paclitaxel—ovarian cancer	0.000505	0.00992	CcSEcCtD
Methyltestosterone—Haemorrhage—Paclitaxel—ovarian cancer	0.000502	0.00987	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.000487	0.0352	CrCbGaD
Methyltestosterone—Norethindrone—PGR—ovarian cancer	0.000482	0.0349	CrCbGaD
Methyltestosterone—Paraesthesia—Vinorelbine—ovarian cancer	0.000477	0.00936	CcSEcCtD
Methyltestosterone—Angiopathy—Paclitaxel—ovarian cancer	0.000456	0.00895	CcSEcCtD
Methyltestosterone—Alopecia—Paclitaxel—ovarian cancer	0.000444	0.00872	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000429	0.00842	CcSEcCtD
Methyltestosterone—Haemoglobin—Docetaxel—ovarian cancer	0.000428	0.0084	CcSEcCtD
Methyltestosterone—Haemorrhage—Docetaxel—ovarian cancer	0.000426	0.00836	CcSEcCtD
Methyltestosterone—Nausea—Chlorambucil—ovarian cancer	0.000414	0.00813	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000397	0.00779	CcSEcCtD
Methyltestosterone—Headache—Topotecan—ovarian cancer	0.000389	0.00763	CcSEcCtD
Methyltestosterone—Angiopathy—Docetaxel—ovarian cancer	0.000386	0.00759	CcSEcCtD
Methyltestosterone—Alopecia—Docetaxel—ovarian cancer	0.000376	0.00739	CcSEcCtD
Methyltestosterone—Levonorgestrel—ESR1—ovarian cancer	0.000376	0.0272	CrCbGaD
Methyltestosterone—Anxiety—Paclitaxel—ovarian cancer	0.000371	0.00729	CcSEcCtD
Methyltestosterone—Nausea—Topotecan—ovarian cancer	0.000369	0.00724	CcSEcCtD
Methyltestosterone—Nausea—Melphalan—ovarian cancer	0.000361	0.00709	CcSEcCtD
Methyltestosterone—Fluoxymesterone—ESR1—ovarian cancer	0.000358	0.0259	CrCbGaD
Methyltestosterone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000357	0.00701	CcSEcCtD
Methyltestosterone—Danazol—ESR1—ovarian cancer	0.000342	0.0247	CrCbGaD
Methyltestosterone—Headache—Vinorelbine—ovarian cancer	0.000332	0.00653	CcSEcCtD
Methyltestosterone—Paraesthesia—Paclitaxel—ovarian cancer	0.000321	0.00629	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—ESR1—ovarian cancer	0.000317	0.0229	CrCbGaD
Methyltestosterone—Nausea—Vinorelbine—ovarian cancer	0.000315	0.00619	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.000307	0.0222	CrCbGaD
Methyltestosterone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000303	0.00594	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—ovarian cancer	0.000289	0.00567	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—ovarian cancer	0.000287	0.00564	CcSEcCtD
Methyltestosterone—Progesterone—PGR—ovarian cancer	0.000281	0.0203	CrCbGaD
Methyltestosterone—Paraesthesia—Docetaxel—ovarian cancer	0.000272	0.00533	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—ovarian cancer	0.000267	0.00525	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—ovarian cancer	0.000266	0.00522	CcSEcCtD
Methyltestosterone—Progesterone—CYP1B1—ovarian cancer	0.000263	0.019	CrCbGaD
Methyltestosterone—Angiopathy—Epirubicin—ovarian cancer	0.000261	0.00512	CcSEcCtD
Methyltestosterone—Alopecia—Epirubicin—ovarian cancer	0.000254	0.00498	CcSEcCtD
Methyltestosterone—Testosterone—CYP1B1—ovarian cancer	0.000248	0.018	CrCbGaD
Methyltestosterone—Angiopathy—Doxorubicin—ovarian cancer	0.000241	0.00474	CcSEcCtD
Methyltestosterone—Alopecia—Doxorubicin—ovarian cancer	0.000235	0.00461	CcSEcCtD
Methyltestosterone—Megestrol acetate—ABCB1—ovarian cancer	0.000224	0.0162	CrCbGaD
Methyltestosterone—Headache—Paclitaxel—ovarian cancer	0.000224	0.00439	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—ovarian cancer	0.000212	0.00417	CcSEcCtD
Methyltestosterone—Nausea—Paclitaxel—ovarian cancer	0.000212	0.00416	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000204	0.00401	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—ovarian cancer	0.000196	0.00385	CcSEcCtD
Methyltestosterone—Headache—Docetaxel—ovarian cancer	0.00019	0.00372	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000189	0.00371	CcSEcCtD
Methyltestosterone—Paraesthesia—Epirubicin—ovarian cancer	0.000183	0.0036	CcSEcCtD
Methyltestosterone—Nausea—Docetaxel—ovarian cancer	0.00018	0.00353	CcSEcCtD
Methyltestosterone—Progesterone—ESR1—ovarian cancer	0.000177	0.0128	CrCbGaD
Methyltestosterone—Paraesthesia—Doxorubicin—ovarian cancer	0.00017	0.00333	CcSEcCtD
Methyltestosterone—Spironolactone—ABCB1—ovarian cancer	0.000139	0.0101	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ABCB1—ovarian cancer	0.000134	0.00973	CrCbGaD
Methyltestosterone—Prednisone—ABCB1—ovarian cancer	0.000131	0.00949	CrCbGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000129	0.00197	CbGpPWpGaD
Methyltestosterone—Norethindrone—ABCB1—ovarian cancer	0.000129	0.00935	CrCbGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000129	0.00196	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.000129	0.00196	CbGpPWpGaD
Methyltestosterone—Headache—Epirubicin—ovarian cancer	0.000128	0.00251	CcSEcCtD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000126	0.00192	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NME2—ovarian cancer	0.000125	0.00191	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000125	0.0019	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000124	0.00189	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—TTF1—ovarian cancer	0.000123	0.00188	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000121	0.00185	CbGpPWpGaD
Methyltestosterone—Nausea—Epirubicin—ovarian cancer	0.000121	0.00238	CcSEcCtD
Methyltestosterone—Prednisolone—ABCB1—ovarian cancer	0.000121	0.00875	CrCbGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	0.000119	0.00182	CbGpPWpGaD
Methyltestosterone—Headache—Doxorubicin—ovarian cancer	0.000118	0.00232	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000118	0.0018	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000118	0.00179	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000117	0.00178	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000116	0.00177	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NME2—ovarian cancer	0.000113	0.00173	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000113	0.00172	CbGpPWpGaD
Methyltestosterone—Nausea—Doxorubicin—ovarian cancer	0.000112	0.0022	CcSEcCtD
Methyltestosterone—AR—Gene Expression—NR5A1—ovarian cancer	0.000112	0.00171	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000112	0.00171	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000109	0.00166	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000108	0.00164	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000106	0.00162	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000102	0.00156	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000102	0.00155	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000101	0.00154	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.0001	0.00153	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	9.76e-05	0.00149	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	9.76e-05	0.00149	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—RAD51C—ovarian cancer	9.73e-05	0.00148	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	9.66e-05	0.00147	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.61e-05	0.00146	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	9.42e-05	0.00144	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	9.41e-05	0.00143	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	9.38e-05	0.00143	CbGpPWpGaD
Methyltestosterone—Hydrocortisone—ABCB1—ovarian cancer	9.25e-05	0.00669	CrCbGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	9.15e-05	0.00139	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9.13e-05	0.00139	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL2—ovarian cancer	9.03e-05	0.00138	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	8.93e-05	0.00136	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.81e-05	0.00134	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.66e-05	0.00132	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	8.62e-05	0.00131	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	8.5e-05	0.0013	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	8.47e-05	0.00129	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	8.39e-05	0.00128	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	8.31e-05	0.00127	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	8.3e-05	0.00127	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	8.29e-05	0.00126	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	8.28e-05	0.00126	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	8.1e-05	0.00124	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	8.1e-05	0.00123	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	8.08e-05	0.00123	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYTB—ovarian cancer	8.07e-05	0.00123	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	8e-05	0.00122	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.89e-05	0.0012	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.83e-05	0.00119	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	7.83e-05	0.00119	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.83e-05	0.00119	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	7.82e-05	0.00119	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.8e-05	0.00119	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	7.79e-05	0.00119	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.74e-05	0.00118	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	7.65e-05	0.00117	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	7.65e-05	0.00117	CbGpPWpGaD
Methyltestosterone—Progesterone—ABCB1—ovarian cancer	7.54e-05	0.00545	CrCbGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	7.53e-05	0.00115	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.51e-05	0.00114	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	7.32e-05	0.00112	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	7.32e-05	0.00112	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYTB—ovarian cancer	7.3e-05	0.00111	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NME2—ovarian cancer	7.27e-05	0.00111	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	7.23e-05	0.0011	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.13e-05	0.00109	CbGpPWpGaD
Methyltestosterone—Testosterone—ABCB1—ovarian cancer	7.12e-05	0.00515	CrCbGaD
Methyltestosterone—SLCO1A2—Metabolism—PPP1CC—ovarian cancer	7.06e-05	0.00108	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—BRIP1—ovarian cancer	7.06e-05	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	7.05e-05	0.00107	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.96e-05	0.00106	CbGpPWpGaD
Methyltestosterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	6.77e-05	0.00103	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	6.73e-05	0.00103	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.67e-05	0.00102	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	6.59e-05	0.001	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	6.59e-05	0.001	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—ovarian cancer	6.58e-05	0.001	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	6.52e-05	0.000994	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.48e-05	0.000988	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	6.43e-05	0.000979	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—YAP1—ovarian cancer	6.39e-05	0.000975	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPP1CC—ovarian cancer	6.38e-05	0.000972	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—BRIP1—ovarian cancer	6.38e-05	0.000972	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	6.34e-05	0.000967	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	6.34e-05	0.000967	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	6.26e-05	0.000955	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	6.22e-05	0.000948	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR1—ovarian cancer	6.19e-05	0.000944	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.18e-05	0.000942	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NME2—ovarian cancer	6.12e-05	0.000933	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.99e-05	0.000913	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.93e-05	0.000904	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—ovarian cancer	5.8e-05	0.000883	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.73e-05	0.000873	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PGR—ovarian cancer	5.58e-05	0.000851	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	5.53e-05	0.000843	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.5e-05	0.000839	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	5.43e-05	0.000827	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	5.42e-05	0.000826	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.35e-05	0.000815	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.32e-05	0.000812	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL6—ovarian cancer	5.3e-05	0.000809	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SPARC—ovarian cancer	5.2e-05	0.000792	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.19e-05	0.000791	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PARP1—ovarian cancer	5.19e-05	0.000791	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.14e-05	0.000784	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	4.88e-05	0.000743	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—YAP1—ovarian cancer	4.73e-05	0.000721	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYTB—ovarian cancer	4.69e-05	0.000714	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.68e-05	0.000714	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	4.67e-05	0.000712	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.65e-05	0.000708	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.5e-05	0.000685	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	4.29e-05	0.000653	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—YAP1—ovarian cancer	4.28e-05	0.000652	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.23e-05	0.000645	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.23e-05	0.000645	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	4.21e-05	0.000642	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PPP2R1A—ovarian cancer	4.21e-05	0.000642	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.12e-05	0.000628	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPP1CC—ovarian cancer	4.1e-05	0.000624	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—BRIP1—ovarian cancer	4.1e-05	0.000624	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.96e-05	0.000603	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYTB—ovarian cancer	3.94e-05	0.000601	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—FASN—ovarian cancer	3.86e-05	0.000588	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.86e-05	0.000588	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.82e-05	0.000583	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	3.8e-05	0.000578	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SOD1—ovarian cancer	3.77e-05	0.000575	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PPP2R1A—ovarian cancer	3.76e-05	0.000572	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	3.74e-05	0.00057	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.72e-05	0.000567	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	3.67e-05	0.000559	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.59e-05	0.000547	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	3.51e-05	0.000536	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—FASN—ovarian cancer	3.49e-05	0.000532	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPP1CC—ovarian cancer	3.45e-05	0.000526	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—BRIP1—ovarian cancer	3.45e-05	0.000526	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	3.43e-05	0.000523	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC5A5—ovarian cancer	3.43e-05	0.000523	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC2A1—ovarian cancer	3.31e-05	0.000505	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NME2—ovarian cancer	3.3e-05	0.000504	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.24e-05	0.000494	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—ovarian cancer	3.22e-05	0.000491	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP1B1—ovarian cancer	3.18e-05	0.000484	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	3.12e-05	0.000475	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.1e-05	0.000473	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.02e-05	0.00046	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR1—ovarian cancer	2.98e-05	0.000454	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.92e-05	0.000445	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ABCB1—ovarian cancer	2.89e-05	0.000441	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TYMS—ovarian cancer	2.84e-05	0.000433	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	2.82e-05	0.000429	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.8e-05	0.000427	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CAV1—ovarian cancer	2.76e-05	0.000421	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.76e-05	0.000421	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—YAP1—ovarian cancer	2.75e-05	0.000419	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.63e-05	0.0004	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ABCB1—ovarian cancer	2.62e-05	0.000399	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMS—ovarian cancer	2.57e-05	0.000392	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CG—ovarian cancer	2.51e-05	0.000383	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.51e-05	0.000383	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—YAP1—ovarian cancer	2.31e-05	0.000352	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CAV1—ovarian cancer	2.29e-05	0.000349	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.29e-05	0.000349	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	2.28e-05	0.000347	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—FASN—ovarian cancer	2.24e-05	0.000341	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CD—ovarian cancer	2.21e-05	0.000337	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC5A5—ovarian cancer	2.2e-05	0.000336	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.19e-05	0.000334	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYTB—ovarian cancer	2.13e-05	0.000325	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC2A1—ovarian cancer	2.13e-05	0.000324	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	2.09e-05	0.000318	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CAV1—ovarian cancer	2.07e-05	0.000315	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP1B1—ovarian cancer	2.04e-05	0.000311	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.01e-05	0.000307	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.98e-05	0.000301	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CB—ovarian cancer	1.93e-05	0.000294	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CG—ovarian cancer	1.89e-05	0.000287	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—FASN—ovarian cancer	1.89e-05	0.000287	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.86e-05	0.000284	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.86e-05	0.000284	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.86e-05	0.000284	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC5A5—ovarian cancer	1.85e-05	0.000283	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	1.83e-05	0.00028	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.81e-05	0.000276	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC2A1—ovarian cancer	1.79e-05	0.000273	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—ovarian cancer	1.77e-05	0.00027	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.75e-05	0.000267	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP1B1—ovarian cancer	1.72e-05	0.000262	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.68e-05	0.000256	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CD—ovarian cancer	1.66e-05	0.000253	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMS—ovarian cancer	1.65e-05	0.000251	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	1.6e-05	0.000244	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MAPK3—ovarian cancer	1.59e-05	0.000243	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—ovarian cancer	1.55e-05	0.000236	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPP2R1A—ovarian cancer	1.52e-05	0.000232	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.52e-05	0.000231	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—ovarian cancer	1.5e-05	0.000229	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NRAS—ovarian cancer	1.49e-05	0.000226	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CB—ovarian cancer	1.44e-05	0.00022	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MAPK3—ovarian cancer	1.42e-05	0.000217	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ABCB1—ovarian cancer	1.41e-05	0.000216	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMS—ovarian cancer	1.39e-05	0.000212	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—ovarian cancer	1.38e-05	0.000211	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MAPK1—ovarian cancer	1.35e-05	0.000206	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CAV1—ovarian cancer	1.33e-05	0.000203	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—ovarian cancer	1.28e-05	0.000195	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.25e-05	0.00019	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—ovarian cancer	1.25e-05	0.00019	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.21e-05	0.000185	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CA—ovarian cancer	1.17e-05	0.000179	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—ovarian cancer	1.14e-05	0.000173	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CAV1—ovarian cancer	1.12e-05	0.000171	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—HRAS—ovarian cancer	1.09e-05	0.000166	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—AKT1—ovarian cancer	1.08e-05	0.000164	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.07e-05	0.000163	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.06e-05	0.000162	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CG—ovarian cancer	1.02e-05	0.000155	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—FASN—ovarian cancer	1.02e-05	0.000155	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1e-05	0.000153	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	9.75e-06	0.000149	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.67e-06	0.000147	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—AKT1—ovarian cancer	9.59e-06	0.000146	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CB—ovarian cancer	9.28e-06	0.000141	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	9.27e-06	0.000141	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CD—ovarian cancer	8.96e-06	0.000137	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CA—ovarian cancer	8.81e-06	0.000134	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	8.22e-06	0.000125	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—ovarian cancer	8.02e-06	0.000122	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKT1—ovarian cancer	7.96e-06	0.000121	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CB—ovarian cancer	7.81e-06	0.000119	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.63e-06	0.000116	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMS—ovarian cancer	7.5e-06	0.000114	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKT1—ovarian cancer	7.19e-06	0.00011	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—ovarian cancer	6.75e-06	0.000103	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CAV1—ovarian cancer	6.04e-06	9.21e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CA—ovarian cancer	5.66e-06	8.62e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.5e-06	8.39e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.84e-06	7.37e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CA—ovarian cancer	4.76e-06	7.26e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKT1—ovarian cancer	4.62e-06	7.04e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.22e-06	6.43e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKT1—ovarian cancer	3.89e-06	5.93e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—ovarian cancer	3.64e-06	5.55e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.57e-06	3.92e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKT1—ovarian cancer	2.1e-06	3.2e-05	CbGpPWpGaD
